No matter how cynical the overall market is, Guardant Health Inc (GH) performance over the last week is recorded -5.37%

Guardant Health Inc (NASDAQ: GH) kicked off on Tuesday, down -3.38% from the previous trading day, before settling in for the closing price of $49.77. Over the past 52 weeks, GH has traded in a range of $20.14-$53.42.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

During the last 5-year period, the sales drop of Healthcare Sector giant was -33.61%. While this was happening, its average annual earnings per share was recorded 23.80%. With a float of $117.75 million, this company’s outstanding shares have now reached $123.65 million.

Let’s determine the extent of company efficiency that accounts for 2021 employees. In terms of profitability, gross margin is 61.34%, operating margin of -58.78%, and the pretax margin is -53.67%.

Guardant Health Inc (GH) Breakdown of a Key Holders of the stock

Our next focus will be how large-scale investors are participating in this stock of the Diagnostics & Research Industry. The insider ownership of Guardant Health Inc is 4.95%, while institutional ownership is 96.52%. The most recent insider transaction that took place on Jul 01 ’25, was worth 5,087,630. In this transaction Co-Chief Executive Officer of this company sold 100,000 shares at a rate of $50.88, taking the stock ownership to the 1,971,830 shares. Before that another transaction happened on Jun 18 ’25, when Company’s Director sold 3,213 for $49.47, making the entire transaction worth $158,947. This insider now owns 7,190 shares in total.

Guardant Health Inc (GH) Recent Fiscal highlights

According to the Wall Street analysts, stocks earnings will be around 23.80% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 22.74% during the next five years compared to -33.61% drop over the previous five years of trading.

Guardant Health Inc (NASDAQ: GH) Trading Performance Indicators

Take a look at Guardant Health Inc’s (GH) current performance indicators. Last quarter, stock had a quick ratio of 3.76. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.70.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.38, a number that is poised to hit -0.72 in the next quarter and is forecasted to reach -2.29 in one year’s time.

Technical Analysis of Guardant Health Inc (GH)

Looking closely at Guardant Health Inc (NASDAQ: GH), its last 5-days average volume was 1.6 million, which is a drop from its year-to-date volume of 2.28 million. As of the previous 9 days, the stock’s Stochastic %D was 22.19%.

During the past 100 days, Guardant Health Inc’s (GH) raw stochastic average was set at 71.25%, which indicates a significant increase from 3.53% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.99 in the past 14 days, which was lower than the 2.59 volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $45.82, while its 200-day Moving Average is $38.76. However, in the short run, Guardant Health Inc’s stock first resistance to watch stands at $49.31. Second resistance stands at $50.53. The third major resistance level sits at $51.23. If the price goes on to break the first support level at $47.38, it is likely to go to the next support level at $46.68. Now, if the price goes above the second support level, the third support stands at $45.46.

Guardant Health Inc (NASDAQ: GH) Key Stats

The company with the Market Capitalisation of 5.96 billion has total of 123,888K Shares Outstanding. Its annual sales at the moment are 739,020 K in contrast with the sum of -436,370 K annual income. Company’s last quarter sales were recorded 203,470 K and last quarter income was -95,160 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.